Effects of Oral Administration of Antrodia Cinnamomea Products for Clinical Symptoms in Spinocerebellar Ataxia Patients
Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This study aims to assess the effect of Antrodia cinnamomea on clinical symptoms in spinocerebellar ataxia patients. To investigate the advancements in neurodegenerative diseases.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 30
Maximum Age: 70
Healthy Volunteers: f
View:
• Adults aged 30 to 70 years, whose native language is Chinese.
• Patients diagnosed with Spinocerebellar Ataxia.
• Subjects with a score below 30 on the Scale for the Assessment and Rating of Ataxia (SARA scale).
• Individuals who can read and write in Chinese and communicate in Chinese.
• Agree to participate in the study.
Locations
Other Locations
Taiwan
National Taiwan University Cancer Center
RECRUITING
Taipei
Contact Information
Primary
Yu Hsuan Chang
hsuan1989@alps.com.tw
+886955551989
Backup
Irene Tsai
ibox526@gmail.com
+886925772995
Time Frame
Start Date: 2024-09-16
Estimated Completion Date: 2027-08-31
Participants
Target number of participants: 60
Treatments
Active_comparator: Stage I: Antrodia Cinnamomea Products + Stage II: Placebo
Crossover design:~During 0 week\~8 weeks is Stage I :~• Dietary Supplement: Antrodia Cinnamomea Products~During 16 weeks\~ 24 weeks is Stage II:~• Dietary Supplement: Placebo
Placebo_comparator: Stage I: Placebo + Stage II: Antrodia Cinnamomea Products
Crossover design:~During 0 week\~8 weeks is Stage I :~• Dietary Supplement: Placebo~During 16 weeks\~ 24 weeks is Stage II:~• Dietary Supplement: Antrodia Cinnamomea Products
Related Therapeutic Areas
Sponsors
Leads: ALPS Biotech CO. LTD